Cite
HARVARD Citation
Veluswamy, R. et al. (2022). Real‐World longitudinal practice patterns in the use of PD‐1 and PD‐L1 inhibitors as First‐Line therapy in patients with Non‐Small cell lung cancer in the United States. Cancer medicine. pp. 4265-4272. [Online].